Department of Internal Medicine

Edward Kim, M.D., Ph.D. View profile as PDF

Edward  Kim

Clinical/Research Interests

Dr. Kim is a gastrointestinal oncologist who specializes in the management of pancreatic, hepatobiliary, gastric, colorectal cancers, and clinical trials for these malignancies. His clinical interests also include head and neck cancers.

Dr. Kim's research focus is on novel developmental therapeutics for gastrointestinal malignancies with a special focus on translational research on pancreatic cancer.

Title:

Assistant Professor of Medicine

Specialty:

Hematology and Oncology, Internal Medicine

Center/Program Affiliation:

Address:

UC Davis Comprehensive Cancer Center
4501 X St., Suite 2nd floor
Sacramento, CA 95817

Phone:

916-734-5959

Education:

Stony Brook University
Stony Brook, New York
M.D. 2005

Stony Brook University
Stony Brook, New York
Ph.D. 2003

Harvard University
Cambridge, Massachusetts
A.B. 1997

Residency:

University of Michigan
Ann Arbor, MI
2007
Internal Medicine

Fellowships:

University of Michigan
Ann Arbor, MI
2011
Hematology/Oncology

Board Certifications:

American Board of Internal Medicine, Medical Oncology, 2011
American Board of Internal Medicine, 2008

Professional Memberships:

American Association for Canter Research (AACR)
American Society of Clinical Oncology (ASCO)
Southwest Oncology Group (SWOG)

Honors and Awards:

ASCO Cancer Foundation Merit Award – GI Cancers Symposium, 2011
Chief Fellow, 2010-11
Mark Roth Memorial Award, 2010

Select Recent Publications:

Devata, S., Kim, E.J. Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor. Case Rep Oncol. 2012 Nov; 5:622–626.

Yen, W., Fischer, M.F., Hynes, M., Wu, J.J., Kim, E., Beviglia, L., Yeung, V.P., Song, X., Kapoun, A.M., Lewicki, J., Gurney, A., Simeone, D.M., Hoey, T. Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells. Clin Canc Res. 2012 Oct; 18:5374-86

Kim, E.J., Simeone, D.M. Advances in Pancreatic Cancer. Curr Opin Gastroenterol. 2011 Sep;27:460-6.

Kim, E.J., Zalupski,M.M. Systemic Therapy for Advanced Gastrointestinal Stromal Tumors: Beyond Imatinib. J Surg Oncol. 2011 Dec;104(8):901-6.

Kim E, Zalupski MM. Non-surgical treatment of hepatocellular carcinoma: Systemic therapies for advanced hepatocellular carcinoma: Review of current status of chemotherapy for the treatment of hepatocellular carcinoma, in Hussain HK and Francis IR, Eds. Primary carcinomas of the liver, New York, Cambridge University Press 2009: 113-121 (Book Chapter)

Helfman, D.M., Kim, E.J., Lukanidin, E., Grigorian, M. The Metastasis Associated Protein S100A4. Br J Cancer. 2005 Jun 6;92(11):1955-8.

Kim, E. J., and Helfman, D. M. Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin. J Biol Chem. 2003 Aug 8;278(32):30063-73.

Araya, E., Berthier, C., Kim, E., Yeung, T., Wang, X., and Helfman, D. M. Regulation of coiled-coil assembly in tropomyosins. J Struct Biol. 2002 Jan-Feb;137(1-2):176-83.

Edward Kim is currently accepting new patients. To schedule an appointment, please call 916-703-5210